Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
01/2001
01/04/2001WO2001000206A1 Vla-4 inhibitor compounds
01/04/2001CA2383546A1 Src kinase inhibitor compounds
01/04/2001CA2376785A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
01/04/2001CA2376758A1 Hexahydropyrrolo¬1,2-c|pyrimidines as antiviral, antifungal and/or antitumor agents
01/04/2001CA2369308A1 Vla-4 inhibitor compounds
01/03/2001EP1065209A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them
01/03/2001EP1064285A1 Novel cephalotaxane derivatives and process for their preparation
01/03/2001EP0708776B1 Antiallergic imidazoazepines
01/03/2001CN1278823A 1'-[4-[1-(4-Fluorophenyl)-1(H)-indole-3-yl]-1-butyl]-spiro [isobenzofuran-1(3(H),4'-piperidine] hydrohalogenides
01/03/2001CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
01/03/2001CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity
01/03/2001CN1278796A Method for the synthesis of quinoline derivatives
01/03/2001CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors
01/03/2001CN1060175C Method for prepn. of 3-formyl-cephem derivatives
01/02/2001US6169188 Treating cyclooxygenase-2 mediated diseases
01/02/2001US6169097 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives
01/02/2001US6169092 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
01/02/2001US6169091 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/02/2001US6169090 Heterocyclic compounds and their therapeutic use
01/02/2001US6169080 Highly lipophilic camptothecin derivatives
01/02/2001CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
01/02/2001CA2013449C Antibacterial 5-alkylquinolonecarboxylic acids
01/02/2001CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
12/2000
12/28/2000WO2000078765A2 CHROMENO[4,3,2-de]ISOQUINOLINES AS POTENT DOPAMINE RECEPTOR LIGANDS
12/28/2000WO2000078724A2 Imidazolinderivatives their preparation and their pharmaceutical use
12/28/2000CA2373497A1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062205A2 Inhibitors of phospholipase enzymes
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000CN1278251A Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists
12/27/2000CN1278249A Biphenyl derivatives as pharmaceuticals
12/27/2000CN1278248A [Indole] naphthopyrans, prepn., compositions and (co) polymer matrics contg. them, synthesis intermediates
12/26/2000US6166209 Piperidine derivatives
12/26/2000US6166034 Spiro piperidine derivatives as 5HT1D receptor antagonists
12/26/2000CA2203494C Energy transfer dyes with enhanced fluorescence
12/21/2000WO2000077010A2 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077006A1 Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-b)-indole-1-acetic acid esters in a hydroxylic solvent
12/21/2000WO2000077005A1 Naphthopyrans annelated in c5-c6 with a lactam-type c6 ring and compositions and (co)polymer containing them
12/21/2000WO2000077002A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077001A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000076990A1 New compounds
12/21/2000WO2000076984A2 Novel compounds, their use and preparation
12/21/2000WO2000050426A3 Furo[3, 2-b]pyridines as 5-ht1f agonists
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2375860A1 Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-b)-indole-1-acetic acid esters in a hydroxylic solvent
12/21/2000CA2375857A1 Naphthopyrans annelated in c5-c6 with a lactam-type c6 ring and compositions and (co)polymer containing them
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/20/2000EP1061081A1 7-Oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridine carboxylate derivatives, process for their preparation and pharmaceutical compositions containing them
12/20/2000EP1060179A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
12/20/2000EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists
12/20/2000EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
12/20/2000EP0714295B1 Fibrinogen receptor antagonists
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277200A Process for producing hexahydrothiopheno-[3,4-d] imidazole-2,4-diketones compound
12/19/2000US6162798 Cerebrovascular contraction after subarachnoid hemorrhage with quinoline compounds
12/14/2000WO2000075236A1 Extended rhodamine compounds useful as fluorescent labels
12/14/2000WO2000075145A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000WO2000075127A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/14/2000CA2390948A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000CA2370013A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/14/2000CA2365075A1 Extended rhodamine compounds useful as fluorescent labels
12/13/2000EP1058549A1 THROMBIN OR FACTOR Xa INHIBITORS
12/13/2000CN1276370A Process for preparing anticancer compound, and intermediate
12/12/2000US6160133 Stereospecific biosynthesis of the alcohol by enzymatic reduction of the corresponding aldehyde or ketone using a candida, zygosaccaromyces, or mortierrela microorganism
12/12/2000US6160119 Fused dihydropyrans
12/12/2000US6160003 Antitumor and anticarcinogenic agents
12/12/2000US6160001 Halobenzimidazoles and their use as microbicides
12/12/2000US6159967 such as 1-(2-((2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl) morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1-(3H), 4'-piperidine)-(2S)-oxide; respiratory disease such as asthma
12/07/2000WO2000073305A1 Preparation of camptothecin and nothapodytine derivatives
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2340012A1 Preparation of camptothecin and nothapodytine derivatives
12/06/2000EP1057819A1 Phthalazine derivatives and remedies for erectile dysfunction
12/06/2000EP1057814A1 Tetrahydrobenzindole derivatives
12/06/2000EP1056717A1 Arylphenyl-substituted cyclic keto-enols
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/05/2000US6156897 Method for purifying 20(S)-camptothecin
12/05/2000US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
12/05/2000US6156772 Indole hormone inhibitors
12/05/2000US6156762 Indolomorphinan derivative and agent for curing and preventing cerebral disorder
12/05/2000US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives
12/05/2000US6156494 Solid phase synthesis using substrate having regions, each region is an optical fiber having covalently bound reactive groups; fibers are used to direct light, heat or both to compounds tethered to its surface
11/2000
11/30/2000WO2000071541A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
11/30/2000WO2000071534A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000CA2716369A1 Phenoxypropylamine compounds
11/30/2000CA2373793A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054870A1 Heterocyclic topoisomerase poisons
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000CN1275124A Phthalazine derivatives and remedies for erectile dysfunction
11/29/2000CN1274723A Dicyclic compound, medicine composition containing the same and use thereof
11/29/2000CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/29/2000CN1058967C Novel pyridine compounds, processes for their preparation and pharmaceutical compositions thereof
11/28/2000US6153655 Terminally-branched polymeric linkers and polymeric conjugates containing the same